AGAWAM, Mass., April 5 Critical information that dietary supplement manufacturers must know in order to meet the Federal Food & Drug Administration's (FDA) good manufacturing practices "compliance paradigm" is presented in a free white paper, available now for download from http://www.microtestlabs.com/dietarypaper.
The white paper, "Dietary Supplements -- A New Paradigm for Manufacturers," provides how-to guidance for manufacturers of dietary supplements - a fast-growing market, which totaled $23 billion and more than 40,000 products in 2008.
Just 15 years ago, the production of dietary supplements was regulated as food ingredients without oversight. Today, the FDA regulates their manufacture under the current Good Manufacturing Practices (cGMP) for Dietary Supplements, listed in 21 Code of Federal Regulations (CFR) 111.
"Today, there's a new paradigm for dietary supplement manufacturers - and it's one of testing, manufacturing, and lot release. cGMP controls are used to assure that products meet the requirements of safety and have the strength and identity to meet the label claims. And label claims are the driver for all FDA regulatory actions," said Steven G. Richter, Ph.D., RAC, SM (NRM), author of the white paper, and President and Chief Scientific Officer of Microtest Laboratories.
"In fact, this new 'compliance paradigm' dietary supplement manufacturers is very similar to pharmaceutical manufacturing. The problem is that, for many small- and medium-sized companies which produce dietary supplements, compliance with the spirit and intent of the cGMPs is proving to be a challenge," he said.
For those manufacturers, the white paper provides a much needed overview and discussion of what's required of the by the FDA, including how-to guidance on:
The white paper is available at: http://www.microtestlabs.com/dietarypaper.
"The challenges for small and medium sized manufacturers are these: Testing dietary supplements and determining compliance requires the personnel and facilities to handle large-scale testing programs. The ability to train and retain these employees may be a challenge. And a full cGMP assessment is required for each manufacturer.
"Compliance with the intent of the law will be determined by management's buy-in to a robust quality program with concomitant lab support," Richter said. "Given all this, for many small and medium sized manufacturers, outsourcing the majority of their testing may make most economical sense."
For a full discussion of the issues surrounding the FDA's Good Manufacturing Practices (cGMP) for Dietary Supplements, download the new, free white paper, "Dietary Supplements -- A New Paradigm for Manufacturers," from http://www.microtestlabs.com/dietarypaper.
For more information, visit http://www.microtestlabs.com. Follow Microtest Labs on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.
Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, U.S.A., the company's expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Steve Richter, Ph.D.
-- Developing the Necessary Quality System -- Management "Buy In" -- Microbiological Testing/Practices In The USP Dietary Supplement Compendium and FDA BAM -- Chemistry and Manufacturing Controls (CMC)